Sun.Dec 18, 2022

article thumbnail

Swiftly consumer survey: Majority of shoppers struggle to pay grocery bills

Drug Store News

The survey revealed that nearly all respondents are using some form of loyalty tool to offset higher costs due to current economic challenges.

98
article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

We live in unprecedented times, where innovation in biosciences continues to accelerate. Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2023 forecast: FDA revamps cancer drug approvals, and Big Pharma is willing to fall in line

Fierce Pharma

2023 forecast: FDA revamps cancer drug approvals, and Big Pharma is willing to fall in line. aliu. Sun, 12/18/2022 - 17:18.

FDA 95
article thumbnail

Episode 528: Proving you don’t need to repeat cholesterol measurements?

Therapeutics Education Collaboration

In episode 528, James and Mike go through the logic and math around CVD risk estimates with regard to repeat cholesterol measurements. We discuss the impact remeasuring cholesterol has on CVD risk estimates and show that re-measuring every 5-10 years provides minimal if any value when it comes to making treatment decisions. All you need to do is look at a person’s drivers license.

75
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Vaccination decreases risk for development of post-COVID-19 condition

Hospital Pharmacy Europe

Vaccination against COVID-19 appears to provide a small but significant protection against the development of post-COVID-19 condition. Patients who have a COVID-19 vaccination reduce their risk of subsequently developing post-COVID-19 condition (or long covid) although the effectiveness of the vaccine is low according to the findings of a meta-analysis by US researchers.

article thumbnail

2023 BCPS Exam – What You Need To Know

Med Ed 101

The 2023 BCPS exam will not undergo significant changes compared to 2022. In the ten years I have spent following, studying, and providing study materials for this exam, there have been about 3-4 major changes. There are no planned changes to the content outline for 2023. In this article, I will outline previous pass rates, […]. The post 2023 BCPS Exam – What You Need To Know appeared first on Med Ed 101.

52

More Trending

article thumbnail

Dry Cough Remedies You Need To Know

BuzzRx

Coughing is a natural reflex and defense mechanism by which the body removes irritants from the respiratory tract. Though coughing can be unpleasant or even painful if it happens for a long time, coughing protects the body by removing irritants from your lungs and airways. There are different types of coughs based on their duration and the sound they make.

article thumbnail

FDA Publishes Draft Guidance on Voluntary Malfunction Summary Reporting Program for Medical Devices

The FDA Law Blog

By McKenzie E. Cato & Allyson B. Mullen — On December 9, 2022, FDA issued a draft guidance document on the Voluntary Malfunction Summary Reporting (VMSR) Program for medical devices. Generally, FDA’s MDR regulations require device manufacturers to submit Medical Device Reports (MDRs) for individual reportable malfunctions within 30 calendar days of the manufacturer becoming aware of the malfunction.

FDA 59
article thumbnail

EMA CHMP recommends Moderna’s Covid-19 booster for children

Pharmaceutical Technology

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting variation to the marketing authorization (MA) for Moderna ’s Spikevax bivalent Original/Omicron BA.1 (mRNA-1273.214) booster for usage in children aged six to 11 years. The 0.25mL dose of the booster vaccine could potentially be used in the European Union (EU) following authorisation in these children a minimum of three months following a previous Covid-19 vaccination.

Vaccines 121